NovImmune SA - Company Review
NovImmune SA - Company ReviewSummary
NovImmune SA (NovImmune) is a biopharmaceutical company that discovers and develops antibody-based drugs for the treatment of inflammatory diseases, immune-related disorders and cancer. The company develops pipeline products using its proprietary mAb generating platform, DiversityTrap and kappa-lambda bispecific antibody platform. Its pipeline products include Emapalumab, a human anti-IFN? monoclonal antibody used for the treatment of Hemophagocytic Lymphohistiocytosis; NI-0101, a toll-like receptor 4 monoclonal antibody; NI-1201, a monoclonal antibody intended to interact with IL-6 receptor to suppress Interleukin-6 (IL-6) driven inflammation; and others. The company has partnership with various pharmaceutical companies, to develop monoclonal and bispecific antibodies. It has a presence in Geneva and Basel, Switzerland. NovImmune is headquartered in Geneva, Switzerland.
This comprehensive company report of NovImmune SA provides you with company's businesses and operations information.
The profile contains critical company information including,
- Company Overview - A detailed description of the company's operations and business divisions.
- Major products and services - A list of major products, services and brands of the company.
- Key competitors - A list of key competitors to the company.
- Key employees - A list of the key executives of the company.
- Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
GlobalData is a one-stop solution for actionable insight into the pharmaceutical and medical device sectors. Together with the best team of researchers, analysts, epidemiologists and consultants, and an unmatched suite of proprietary databases, we provide high-quality, accurate and transparent insight that can help you achieve growth and increase business value.
Our valuable research and consulting solutions ensure you stay at the forefront of the industry by integrating accurate market forecasts and healthcare analytics on the latest trends and developments. Among other benefits, our informed healthcare industry perspectives have assisted businesses based across the pharmaceuticals, biotechnology and medical equipment markets in making strategic decisions that have increased the value of their products and services.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.